Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lateral Ridge Augmentation Using Allograft Bone Particles Hydrated With or Without rhPDGF
NCT04954664Recruiting
- Sponsor
- University of Alabama at Birmingham
- Start
- Aug 2021
- Primary completion
- Dec 2026
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Randomised, single-blind trial of GEM 21S in osteoporosis (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Quantitative histomorphometric evaluation of new bone formation at 4 months. Started Aug 2021; status: recruiting.
02
Drugs
GEM 21S
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT04954664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04954664.